Immunohistochemical Expression of BCL-2 in Endometrial Carcinoma and Its Comparison With Hormone Receptor Status and Epidermal Growth Factor

Background: Endometrial carcinoma is the most common malignant tumor of the female genital tract with increasing incidence in developed countries. In the era of targeted therapy, immunohistochemical markers play an important role in the treatment and prognosis of endometrial carcinoma. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandaswamy, Sharanya, Palanisamy, Poongothai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896848/
https://www.ncbi.nlm.nih.gov/pubmed/36751174
http://dx.doi.org/10.7759/cureus.33346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896848/
https://www.ncbi.nlm.nih.gov/pubmed/36751174
http://dx.doi.org/10.7759/cureus.33346

Ejemplares similares